✨
AI Summary
- Ryan Beal discusses biopharma leadership.
- Dyve Biosciences targets pH modulation for immune and cancer diseases.
- Focus on delivering targeted therapies for better patient outcomes.
Guests on This Episode
RB
Ryan Beal
1 podcast appearance